- Home
- PETS vs FORA Comparison
PETS vs FORA Comparison
Compare PETS & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PETS | FORA |
|---|---|---|
| Founded | 1996 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Drug Stores and Proprietary Stores | Computer Software: Prepackaged Software |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.6M | 66.2M |
| IPO Year | 2003 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PETS | FORA |
|---|---|---|
| Price | $2.50 | $2.06 |
| Analyst Decision | Sell | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.20 | N/A |
| AVG Volume (30 Days) | ★ 122.5K | 16.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $273,800,000.00 | $20,153,263.00 |
| Revenue This Year | N/A | $51.82 |
| Revenue Next Year | $2.98 | $7.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.57 | $1.64 |
| 52 Week High | $4.32 | $2.71 |
Technical Indicators
Market Signals| Indicator | PETS | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 28.07 | 48.17 |
| Support Level | $2.44 | $2.05 |
| Resistance Level | $2.93 | $2.12 |
| Average True Range (ATR) | 0.11 | 0.02 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 5.07 | 50.00 |
Price Performance
Historical ComparisonAbout PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.